Empiriko
Pre-clinicalEmpiriko is a biotech company focused on developing targeted radioligand therapies and antibody drug conjugates for cancer and next generation point-of-care diagnostics.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Funding information not available
About
Empiriko is a biotech company focused on developing targeted radioligand therapies and antibody drug conjugates for cancer and next generation point-of-care diagnostics.
Drug DeliverySmall Molecules